Trials / Active Not Recruiting
Active Not RecruitingNCT01953159
Assessment of Paclitaxel-Induced Neuropathy
Validation of a Polygenic Neurotoxicity Risk Score in Patients With Unusually Severe Paclitaxel-Induced Neuropathy
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to collect clinical data, blood samples, and self reported symptoms from patients that experience unusually severe neuropathy after treatment with paclitaxel. This data will be used to develop predictive markers for neuropathy. Blood samples will be used to create induced pluripotent stem (iPS) cells and eventually artificial nerve cells to be used to study neuropathy in the lab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Collection | |
| OTHER | Patient Questionnaires |
Timeline
- Start date
- 2013-08-29
- Primary completion
- 2027-05-19
- Completion
- 2027-12-01
- First posted
- 2013-09-30
- Last updated
- 2025-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01953159. Inclusion in this directory is not an endorsement.